Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) entered into a settlement agreement with Teva Pharmaceuticals Industries Ltd ...
Catalyst stock gains 17% as it settles Firdapse patent litigation with Teva protecting the drug's exclusivity in the United ...
The board also includes former RBI deputy governors Jagdish Capoor, Rakesh Mohan and Anand Sinha and former UIDAI chairman J ...
Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing ...
As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035. CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceut ...
Their partner, Delhi-based Anup Let, shared two pieces, ‘Scent’ and ‘Botanical Perspective’. They said, “This exhibition has ...